Related Experiment Video
Updated: Apr 13, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
30.0K
Autistic spectrum disorder, epilepsy, and vagus nerve stimulation
Mariam Mettry Hull1, Deepak Madhavan, Charles M Zaroff
1Nebraska Comprehensive Epilepsy Program, Nebraska Medical Center, Omaha, NE, 982045, USA.
Summary
Vagus nerve stimulation (VNS) may improve behavior in children with autistic spectrum disorder (ASD) and epilepsy. This treatment showed modest behavioral gains independent of seizure control, suggesting potential benefits beyond epilepsy management.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Neurology
Background:
- Autistic spectrum disorder (ASD) frequently co-occurs with epilepsy.
- Medically refractory epilepsy in ASD presents significant management challenges.
- Vagus nerve stimulation (VNS) is an established epilepsy treatment with potential behavioral effects.
Observation:
- A case report details a 10-year-old boy with ASD and refractory epilepsy.
- The patient received vagus nerve stimulation after failure of antiepileptic drugs.
- Longitudinal and quantitative data were used to assess behavioral side effects.
Findings:
- Vagus nerve stimulation led to initial, albeit temporary, seizure control.
- Modest improvements in behavior and development were observed.
- Behavioral improvements occurred independently of seizure reduction.
Implications:
- VNS may offer a dual benefit for individuals with ASD and epilepsy, addressing both seizures and behavior.
- The mechanisms underlying VNS-induced behavioral improvements in ASD require further investigation.
- This case suggests VNS as a potential therapeutic option for behavioral challenges in ASD, warranting further research.
Related Concept Videos
01:19Autism Spectrum Disorder
1.9K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.9K
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:13Seizures: Classification
2.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
01:30Electroconvulsive Therapy
2.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.3K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
01:18Disorders of the Autonomic Nervous System
2.0K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
2.0K